Additional Information

Description

Naloxone 0.4 mg/mL 1 mL SDB BX/10 is an opioid antagonist used for the emergency reversal of opioid overdoses. Naloxone, a potent antagonist at opioid receptors, effectively displaces opioids from these receptors and reverses their effects, including respiratory depression and sedation. This formulation is specifically designed for rapid administration in critical situations where immediate reversal of opioid effects is required.

The product is supplied in a single-dose box containing ten vials, each with a concentration of 0.4 mg/mL in a 1 mL volume. This allows for precise dosing and easy application in emergency scenarios. The single-dose vial (SDB) format ensures that the solution remains sterile and uncontaminated until use, providing a reliable option for first responders and healthcare professionals.

Naloxone works by competitively binding to opioid receptors in the central nervous system, thereby reversing the effects of opioid toxicity. Its rapid onset of action is critical in restoring normal respiratory function and consciousness in patients experiencing an opioid overdose. The solution is administered via intravenous, intramuscular, or subcutaneous injection, depending on the clinical situation.

Proper administration of Naloxone 0.4 mg/mL 1 mL requires prompt action and adherence to dosing guidelines. Common side effects include withdrawal symptoms, agitation, and nausea, particularly in opioid-dependent individuals.